Anne-Mieke Vandamme
AuthID: R-000-Q27
321
TITLE: Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy
AUTHORS: Daelemans, D; Vandamme, AM; De Clercq, E;
PUBLISHED: 1999, SOURCE: ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, VOLUME: 10, ISSUE: 1
AUTHORS: Daelemans, D; Vandamme, AM; De Clercq, E;
PUBLISHED: 1999, SOURCE: ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, VOLUME: 10, ISSUE: 1
INDEXED IN: 
Scopus 
WOS
Scopus WOS IN MY: 
ORCID | ResearcherID
ORCID | ResearcherID322
TITLE: Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors Full Text
AUTHORS: Walter, H; Schmidt, B; Korn, K; Vandamme, AM; Harrer, T; Uberla, K;
PUBLISHED: 1999, SOURCE: 1998 European-Society-for-Clinical-Virology Meeting on Progress in Clinical Virology IV in JOURNAL OF CLINICAL VIROLOGY, VOLUME: 13, ISSUE: 1-2
AUTHORS: Walter, H; Schmidt, B; Korn, K; Vandamme, AM; Harrer, T; Uberla, K;
PUBLISHED: 1999, SOURCE: 1998 European-Society-for-Clinical-Virology Meeting on Progress in Clinical Virology IV in JOURNAL OF CLINICAL VIROLOGY, VOLUME: 13, ISSUE: 1-2
IN MY: ORCID | ResearcherID
ORCID | ResearcherID323
TITLE: Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes
AUTHORS: Salemi, M; Lewis, M; Egan, JF; Hall, WW; Desmyter, L; Vandamme, AM;
PUBLISHED: 1999, SOURCE: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, VOLUME: 96, ISSUE: 23
AUTHORS: Salemi, M; Lewis, M; Egan, JF; Hall, WW; Desmyter, L; Vandamme, AM;
PUBLISHED: 1999, SOURCE: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, VOLUME: 96, ISSUE: 23
IN MY: ORCID | ResearcherID
ORCID | ResearcherID324
TITLE: Full-length genomic sequence of an HIV type 1 subtype G from Kinshasa
AUTHORS: Oelrichs, RB; Vandamme, AM; Van Laethem, K; Debyser, Z; McCutchan, FE; Deacon, NJ;
PUBLISHED: 1999, SOURCE: AIDS RESEARCH AND HUMAN RETROVIRUSES, VOLUME: 15, ISSUE: 6
AUTHORS: Oelrichs, RB; Vandamme, AM; Van Laethem, K; Debyser, Z; McCutchan, FE; Deacon, NJ;
PUBLISHED: 1999, SOURCE: AIDS RESEARCH AND HUMAN RETROVIRUSES, VOLUME: 15, ISSUE: 6
IN MY: ORCID | ResearcherID
ORCID | ResearcherID325
TITLE: Evidence for a post-Columbian introduction of human T-cell lymphotropic virus [type I] in Latin America (vol 79, pg 2695, 1998)
AUTHORS: Van Dooren, S; Gotuzzo, E; Salemi, M; Watts, D; Audenaert, E; Duwe, S; Ellerbrok, H; Grassmann, R; Hagelberg, E; Desmyter, J; Vandamme, AM;
PUBLISHED: 1999, SOURCE: JOURNAL OF GENERAL VIROLOGY, VOLUME: 80
AUTHORS: Van Dooren, S; Gotuzzo, E; Salemi, M; Watts, D; Audenaert, E; Duwe, S; Ellerbrok, H; Grassmann, R; Hagelberg, E; Desmyter, J; Vandamme, AM;
PUBLISHED: 1999, SOURCE: JOURNAL OF GENERAL VIROLOGY, VOLUME: 80
INDEXED IN: WOS
WOS IN MY: ResearcherID
ResearcherID326
TITLE: Managing Resistance to Anti-HIV Drugs. An Important Consideration for Effective Disease Management Full Text
AUTHORS: Mieke Vandamme; Kristel Van Laethem; Erik De Clercq;
PUBLISHED: 1999, SOURCE: Drugs, VOLUME: 57, ISSUE: 3
AUTHORS: Mieke Vandamme; Kristel Van Laethem; Erik De Clercq;
PUBLISHED: 1999, SOURCE: Drugs, VOLUME: 57, ISSUE: 3
327
TITLE: Broad-spectrum antiviral activity and mechanism of antiviral action of the fluoroquinolone derivative K-12
AUTHORS: Witvrouw, M; Daelemans, D; Pannecouque, C; Neyts, J; Andrei, G; Snoeck, R; Vandamme, AM; Balzarini, J; Desmyter, J; Baba, M; De Clercq, E;
PUBLISHED: 1998, SOURCE: ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, VOLUME: 9, ISSUE: 5
AUTHORS: Witvrouw, M; Daelemans, D; Pannecouque, C; Neyts, J; Andrei, G; Snoeck, R; Vandamme, AM; Balzarini, J; Desmyter, J; Baba, M; De Clercq, E;
PUBLISHED: 1998, SOURCE: ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, VOLUME: 9, ISSUE: 5
INDEXED IN: Scopus WOS
Scopus WOS IN MY: ORCID | ResearcherID
ORCID | ResearcherID328
TITLE: Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations Full Text
AUTHORS: Schmit, JC; Ruiz, L; Stuyver, L; Van Laethem, K; Vanderlinden, I; Puig, T; Rossau, R; Desmyter, J; De Clercq, E; Clotet, B; Vandamme, AM;
PUBLISHED: 1998, SOURCE: JOURNAL OF VIROLOGICAL METHODS, VOLUME: 73, ISSUE: 1
AUTHORS: Schmit, JC; Ruiz, L; Stuyver, L; Van Laethem, K; Vanderlinden, I; Puig, T; Rossau, R; Desmyter, J; De Clercq, E; Clotet, B; Vandamme, AM;
PUBLISHED: 1998, SOURCE: JOURNAL OF VIROLOGICAL METHODS, VOLUME: 73, ISSUE: 1
IN MY: ORCID | ResearcherID
ORCID | ResearcherID329
TITLE: Anti-human immunodeficiency virus drug combination strategies
AUTHORS: Vandamme, AM; Van Vaerenbergh, K; De Clercq, E;
PUBLISHED: 1998, SOURCE: ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, VOLUME: 9, ISSUE: 3
AUTHORS: Vandamme, AM; Van Vaerenbergh, K; De Clercq, E;
PUBLISHED: 1998, SOURCE: ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, VOLUME: 9, ISSUE: 3
INDEXED IN: Scopus WOS
Scopus WOS IN MY: ORCID | ResearcherID
ORCID | ResearcherID330
TITLE: A proline-to-histidine substitution at position 225 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) sensitizes HIV-1 RT to BHAP U-90152
AUTHORS: Pelemans, H; Esnouf, RM; Parniak, MA; Vandamme, AM; De Clercq, E; Balzarini, J;
PUBLISHED: 1998, SOURCE: JOURNAL OF GENERAL VIROLOGY, VOLUME: 79, ISSUE: 6
AUTHORS: Pelemans, H; Esnouf, RM; Parniak, MA; Vandamme, AM; De Clercq, E; Balzarini, J;
PUBLISHED: 1998, SOURCE: JOURNAL OF GENERAL VIROLOGY, VOLUME: 79, ISSUE: 6
INDEXED IN: Scopus WOS
Scopus WOS IN MY: ORCID | ResearcherID
ORCID | ResearcherID